Related Experiment Video

Updated: Jun 24, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Antibiotic use and type 1 diabetes in childhood

Anders Hviid1, Henrik Svanström

  • 1Department of Epidemiology Research, Statens Serum Institut, Copenhagen S, Denmark. aii@ssi.dk

American Journal of Epidemiology
|March 26, 2009
PubMed

Insights

This study found no link between childhood antibiotic use and type 1 diabetes risk. Researchers analyzed data from over 600,000 Danish children, confirming no association across various antibiotic types and usage patterns.

Area of Science:

  • Pediatric Endocrinology
  • Immunology
  • Epidemiology

Background:

  • Emerging evidence suggests a connection between early-life antibiotic exposure and long-term immune system health.
  • The potential impact of childhood antibiotic use on the development of autoimmune diseases like type 1 diabetes requires further investigation.

Purpose of the Study:

  • To investigate the association between antibiotic consumption during childhood and the subsequent risk of developing type 1 diabetes.
  • To analyze if antibiotic class, frequency, or timing of use influences type 1 diabetes incidence in pediatric populations.

Main Methods:

  • A nationwide cohort study encompassing all Danish singleton children born between 1995 and 2003 (n=606,420).
  • Analysis of antibiotic use, categorized by drug class, number of prescriptions, and age at prescription.
  • Estimation of incidence rate ratios for type 1 diabetes in relation to different antibiotic exposure profiles.

Main Results:

  • Overall antibiotic use in childhood showed no statistically significant association with type 1 diabetes (rate ratio = 1.16, 95% CI: 0.91, 1.50).
  • No increased risk of type 1 diabetes was observed based on the number of antibiotic courses, with a minimal rate ratio increase per course (1.02, 95% CI: 0.97, 1.07).
  • Specific antibiotic classes, age at use, or age at type 1 diabetes onset did not reveal any significant associations.

Conclusions:

  • This large-scale prospective study found no evidence to support an association between childhood antibiotic use and the development of type 1 diabetes in Danish children.
  • The findings suggest that antibiotic exposure in early life may not be a significant risk factor for type 1 diabetes.

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...